Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.

Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. Abstract Text:

    karien van der puttenKarien van der Putten,branko braamBranko Braam,kim e jieKim E Jie,carlo ajm gaillardCarlo Ajm Gaillard,karien van der puttenKarien van der Putten,branko braamBranko Braam,kim e jieKim E Jie,carlo a j m gaillardCarlo A J M Gaillard,karien van der puttenKarien van der Putten,branko braamBranko Braam,kim e jieKim E Jie,carlo a j m gaillardCarlo A J M Gaillard,

    Anemia is common in patients who have both heart failure and chronic kidney disease, and there is an association between anemia and progression of both diseases. The main causes of anemia are deficient production of erythropoietin (EPO), iron deficiency, and chronic disease with endogenous EPO resistance. EPO has been successfully used for over a decade to treat anemia in patients with chronic kidney disease. Less obvious are the safety and efficacy of EPO treatment in patients with both heart failure and renal disease. Up to 10% of patients receiving EPO are hyporesponsive to therapy and require large doses of the agent. Several mechanisms could explain resistance to endogenous and exogenous EPO. Proinflammatory cytokines antagonize the action of EPO by exerting an inhibitory effect on erythroid progenitor cells and by disrupting iron metabolism (a process in which hepcidin has a central role). EPO resistance might also be caused by inflammation, which has a negative effect on EPO receptors. Furthermore, neocytolysis could have a role. As resistance to exogenous EPO is associated with an increased risk of death, it is important to understand how cardiorenal failure affects EPO production and function.

    Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. Publishing Authors By Initials

    k van der puttenK van der Putten,b braamB Braam,ke jieKE Jie,ca gaillardCA Gaillard,k van der puttenK van der Putten,b braamB Braam,ke jieKE Jie,ca gaillardCA Gaillard,k van der puttenK van der Putten,b braamB Braam,ke jieKE Jie,ca gaillardCA Gaillard,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Nature clinical practice. Nephrology

    VOLUME: 4

    Page Numbers: 47-57

    Journal Abbreviation:

    ISSN: 1745-8331

    DAY: 20

    MONTH: Jan

    YEAR: 2008

    Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101261800

    Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.

    AFFILIATION: K van der Putten is a Physician and Investigator for the EPOCARES study and CAJM Gaillard is a Nephrologist, in the Department of Internal Medicine, Meander Medical Center, Amersfoort, The Netherlands.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Nat Clin Pract Nephrol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News